業績

{ 111件 }

Miyoshi H, Kameda H, Yamashita K, Nakamura A, Kurihara Y. The protective effect of sodium-glucose cotransporter 2 inhibitors in patients with rapid renal function decline, stage G3 or G4 chronic kidney disease, and type 2 diabetes. J Diabetes Investig in press. (PMID: 31026373)

  • 2019
  • 糖尿病・内分泌グループ
  • 欧文論文/原著

Miyazaki T, Shirakawa J, Nagakura J, Shibuya M, Kyohara M, Okuyama T, Togashi Y, Nakamura A, Kondo Y, Satoh S, Nakajima S, Taguri M, Terauchi Y. Influence of timing of insulin initiation on long-term glycemic control in Japanese patients with type 2 diabetes: a retrospective cohort study. Intern Med, in press

  • 2019
  • 糖尿病・内分泌グループ
  • 欧文論文/原著

Sato M, Miyoshi H, Nakamura A, Sumi N, Kamoshima H, Ono Y. Cross-cultural adaptation of the chronic illness resources survey in Japanese patients with diabetes. Jpn J Nurs Sci, in press

  • 2019
  • 糖尿病・内分泌グループ
  • 欧文論文/原著

Omori K, Nakamura A, Miyoshi H, Takahashi K, Kitao N, Nomoto H, Kameda H, Cho KY, Takagi R, Hatanaka KC, Terauchi Y, Atsumi T. Effects of dapagliflozin and/or insulin glargine on beta cell mass and hepatic steatosis in db/db mice. Metabolism, in press (PMID: 31202833)

  • 2019
  • 糖尿病・内分泌グループ
  • 欧文論文/原著

Yamauchi Y, Nakamura A, Takahashi K, Takase T, Yamamoto C, Yokota I, Atsumi T, Miyoshi H. Factors with remission of fatty liver in patients with type 2 diabetes treated with ipragliflozin. Endocr J, in press

  • 2019
  • 糖尿病・内分泌グループ
  • 欧文論文/原著

Nakamura A, Miyoshi H, Ukawa S, Nakamura K, Nakagawa T, Terauchi Y, Tamakoshi A, Atsumi T.  Proinsulin is sensitive to reflect glucose intolerance. J Diabetes Investig in press. (PMID: 31222973)

  • 2019
  • 糖尿病・内分泌グループ
  • 欧文論文/原著
Hiroshi Nomoto, Hiraku Kameda, Akinobu Nakamura, Kazuhisa Tsuchida, So Nagai, Tatsuya Atsumi, Hideaki Miyoshi Breakdown of autonomously functioning thyroid nodule accompanied by acromegaly after octreotide treatment Frontiers in Endocrinology, in press.(PMID: 30881346)
  • 2019
  • 糖尿病・内分泌グループ
  • 欧文論文/症例報告
Shibayama Y, Kameda H, Ota S, Tsuchida K, Cho KY, Nakamura A, Miyoshi H, Atsumi T. A case of fulminant type 1 diabetes induced by the anti-programmed death-ligand 1 antibody, avelumab. J Diabetes Investig. 2019 (PMID: 30738003)
  • 2019
  • 糖尿病・内分泌グループ
  • 欧文論文/症例報告
  • 2018
  • 糖尿病・内分泌グループ
  • 2017
  • 糖尿病・内分泌グループ